Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
Open | $14.690 |
Close | - |
Volume / Avg. | 122.872K / 418.330K |
Day Range | 14.380 - 14.910 |
52 Wk Range | 12.605 - 30.850 |
Market Cap | $876.480M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 11.43% |
Days to Cover | 13.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by Needham on Tuesday, March 12, 2024. The analyst firm set a price target for 38.00 expecting PLRX to rise to within 12 months (a possible 155.89% upside). 30 analyst firms have reported ratings in the last year.
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $14.85 last updated Today at March 28, 2024 at 3:08 PM EDT.
There are no upcoming dividends for Pliant Therapeutics.
Pliant Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Pliant Therapeutics.
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.